Dustin S. Sjuts

Insider Reports History

Entity
Individual
Location
7555 Gateway Blvd, Newark, CA
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dustin S. Sjuts:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. President Common Stock 168K $845K $5.04 Mar 18, 2024 Direct

Insider Reports Filed by Dustin S. Sjuts

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Mar 15, 2024 2 -$62.2K 4 Mar 19, 2024 President
RVNC Revance Therapeutics, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 President
RVNC Revance Therapeutics, Inc. Dec 31, 2023 1 $1.97K 4 Jan 3, 2024 President
RVNC Revance Therapeutics, Inc. Dec 15, 2023 1 -$38.1K 4 Dec 18, 2023 President
RVNC Revance Therapeutics, Inc. Aug 11, 2023 2 -$168K 4 Aug 15, 2023 President
RVNC Revance Therapeutics, Inc. Jun 30, 2023 1 $15.6K 4 Jul 5, 2023 President
RVNC Revance Therapeutics, Inc. Jun 9, 2023 1 -$154K 4 Jun 13, 2023 President
RVNC Revance Therapeutics, Inc. Mar 15, 2023 1 -$90.9K 4 Mar 17, 2023 President
RVNC Revance Therapeutics, Inc. Feb 15, 2023 1 -$91.9K 4 Feb 16, 2023 President
RVNC Revance Therapeutics, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 President
RVNC Revance Therapeutics, Inc. Dec 31, 2022 1 $7.37K 4 Jan 3, 2023 President
RVNC Revance Therapeutics, Inc. Dec 15, 2022 1 -$62.7K 4 Dec 16, 2022 President
RVNC Revance Therapeutics, Inc. Sep 22, 2022 2 -$679K 4 Mar 9, 2023 President
RVNC Revance Therapeutics, Inc. Jun 30, 2022 1 $11.7K 4 Jul 5, 2022 President
RVNC Revance Therapeutics, Inc. Mar 15, 2022 1 -$29K 4 Mar 17, 2022 President
RVNC Revance Therapeutics, Inc. Feb 15, 2022 2 -$32.4K 4 Feb 17, 2022 President
RVNC Revance Therapeutics, Inc. Feb 2, 2022 2 -$726K 4 May 16, 2023 President
RVNC Revance Therapeutics, Inc. Feb 2, 2022 1 $0 4 Feb 4, 2022 President
RVNC Revance Therapeutics, Inc. Dec 15, 2021 1 -$8.17K 4 Dec 17, 2021 President
RVNC Revance Therapeutics, Inc. Nov 9, 2021 1 $0 4 Nov 10, 2021 President
RVNC Revance Therapeutics, Inc. Jun 30, 2021 1 $21.2K 4 Jul 2, 2021 Chief Commercial Officer